Post-relapse overall survival | |||
HR | 95% CI | p-value | |
Age at first relapse (years) | 0.4 | ||
≤ 60 | 1 | Ref. | |
> 60 | 0.9 | (0.70 to 1.15) | |
FIGO stage | 0.525 | ||
IIIC | 1 | Ref. | |
IV | 0.9 | (0.66 to 1.23) | |
Cycles of NACT | |||
0 | 1 | Ref. | |
3-4 | 1.31 | (0.96 to 1.79) | 0.084 |
6 | 1.53 | (1.11 to 2.13) | 0.01 |
Time to first recurrence | 0.95 | (0.93 to 0.96) | <0.001 |
Pattern of recurrence | |||
Peritoneal | 1 | Ref. | |
Lymph node | 0.42 | (0.27 to 0.64) | <0.001 |
Pleural or pulmonary | 1.13 | (0.81 to 1.58) | 0.462 |
Other (metastatic) | 1.02 | (0.74 to 1.40) | 0.91 |
CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; HR, hazard ratio; NACT, neoadjuvant chemotherapy; Ref., reference? please confirm.